Zanella-Cleon Isabelle, Becchi Michel, Lacan Philippe, Giordano Piero C, Wajcman Henri, Francina Alain
Institut de Biologie et de Biochimie des Protéines, IFR128, Université Claude Bernard-Lyon I, Lyon, France.
Clin Chem. 2008 Jun;54(6):1053-9. doi: 10.1373/clinchem.2007.097857. Epub 2008 Apr 17.
Hemoglobin (Hb) Groene Hart [alpha119 (H2)Pro-->Ser (alpha1)], also known as Hb Bernalda, is a nondeletional alpha-thalassemic Hb variant that is frequent in southern Italy and North Africa. This variant is not supposed to be produced in the erythrocytes of carriers. The alpha-thalassemic behavior of this variant has been explained as an impaired interaction between the alpha-globin chain and the alpha-Hb-stabilizing protein.
To separate globin chains, we developed a modified reversed-phase liquid chromatography (RPLC) procedure that uses acetonitrile-water solvents containing up to 3 mL/L trifluoroacetic acid. After RPLC, we characterized the isolated globin chains by electrospray ionization (ESI) mass spectrometry (MS) and analyzed their tryptic peptides with matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS and nano-LC-ESI-MS/MS.
RPLC detected an abnormal peak with a retention time substantially greater than that of the wild-type alpha(A)-globin chain. We identified this variant as Hb Groene Hart and found it in the hemolysates of 11 unrelated patients (1 homozygote, 9 heterozygotes, and 1 heterozygote associated with the -alpha(3.7) deletion). These patients possessed abnormal hematologic features suggesting an alpha-thalassemia phenotype. Molecular modeling suggested that the increase in hydrophobicity was due to opening of the GH interhelical segment following replacement of amino acid residue 119 with a nonhelix breaker residue.
This method allows the detection of Hb variants at low concentrations, and adjusting the composition of the organic solvents enables the method to identify Hb variants with large changes in hydrophobicity.
血红蛋白(Hb)格罗内·哈特[α119(H2)脯氨酸→丝氨酸(α1)],也称为Hb贝尔纳达,是一种非缺失型α地中海贫血血红蛋白变体,在意大利南部和北非较为常见。这种变体在携带者的红细胞中不应该产生。这种变体的α地中海贫血行为被解释为α珠蛋白链与α血红蛋白稳定蛋白之间的相互作用受损。
为了分离珠蛋白链,我们开发了一种改良的反相液相色谱(RPLC)方法,该方法使用含有高达3 mL/L三氟乙酸的乙腈 - 水溶剂。RPLC之后,我们通过电喷雾电离(ESI)质谱(MS)对分离出的珠蛋白链进行表征,并用基质辅助激光解吸/电离飞行时间(MALDI-TOF)MS和纳升液相色谱 - ESI-MS/MS分析其胰蛋白酶肽段。
RPLC检测到一个异常峰,其保留时间明显长于野生型α(A)珠蛋白链。我们将此变体鉴定为Hb格罗内·哈特,并在11名无亲缘关系的患者(1名纯合子、9名杂合子和1名与 -α(3.7)缺失相关的杂合子)的溶血产物中发现了它。这些患者具有提示α地中海贫血表型的异常血液学特征。分子建模表明,疏水性增加是由于用非螺旋破坏残基取代氨基酸残基119后GH螺旋间段的开放。
该方法能够检测低浓度的Hb变体,并且通过调整有机溶剂的组成,该方法能够鉴定疏水性有较大变化的Hb变体。